Standardized MR protocol for the evaluation of MRA sequences and/or contrast agents effects in high-degree arterial stenosis analysis

Magnetic Resonance Materials in Physics, Biology and Medicine

Volumn 14, Issue 3, 2002, Pages 259-267

  Marchand, Bruno ^a,b   Douek, Philippe C ^a,c   Robert, Philippe ^d   Corot, Claire ^d   Roux, Jean Pierre ^a   Adeleine, Patrice ^e   Hernandez Hoyos, Marcela ^a   Cremillieux, Yannick ^f   Orkisz, Maciej ^a   Canet, Emmanuelle ^a  

^a UNIVERSITÉ DE LYON   (France)

^b CROIX ROUSSE HOSPITAL   (France)

^c LOUIS PRADEL HOSPITAL   (France)

^d Laboratoire Guerbet   (France)

^e Biostatistiques Et Informatique Médicale ^*  (France)

^f UNIVERSITÉ LYON 1   (France)

Author keywords

Arteries; Contrast agent; Experimental study; Gadolinium; MR angiography; Stenosis or obstruction

Indexed keywords

CONTRAST MEDIUM; GADOTERIC ACID; P 760; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; GADOLINIUM 1,4,7,10-TETRAAZACYCLODODECANE-N,N',N'',N'''-TETRAACETATE; GADOLINIUM COMPOUND P760; HETEROCYCLIC COMPOUND; ORGANOMETALLIC COMPOUND;

ARTERY OCCLUSION; ARTICLE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; EXPERIMENTATION; IMAGE ANALYSIS; MAGNETIC RESONANCE ANGIOGRAPHY; NONHUMAN; OPTICAL RESOLUTION; PHANTOM; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; THREE DIMENSIONAL IMAGING; ARTERY; BIOLOGICAL MODEL; DOSE RESPONSE; HISTOLOGY; HUMAN; IMAGE QUALITY; INSTRUMENTATION; METHODOLOGY; PATHOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; QUALITY CONTROL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARD; STENOSIS, OCCLUSION AND OBSTRUCTION;

ARTERIAL OCCLUSIVE DISEASES; ARTERIES; CONSTRICTION, PATHOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; HETEROCYCLIC COMPOUNDS; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MODELS, CARDIOVASCULAR; ORGANOMETALLIC COMPOUNDS; PHANTOMS, IMAGING; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; HUMANS;

EID: 18444396573     PISSN: 13528661     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1352-8661(02)00071-6     Document Type: Article

References (46)

1. Three-dimensional contrast-enhanced MR angiography
2. Three-dimensional gadolinium-enhanced MR angiography of thoracic aorta
3. Three-dimensional contrast-enhanced magnetic resonance angiography of thoracic vasculature
4. Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches
5. Dynamic gadolinium-enhanced three-dimensional abdominal MR arteriography
6. Role of magnetic resonance angiography for assessment of abdominal aortic aneurysm before endoluminal repair
7. Preoperative assessment of the carotid bifurcation. Can magnetic resonance angiography and duplex ultrasonography replace contrast arteriography
8. Test bolus examination in the carotid artery at dynamic gadolinium-enhanced MR angiography
9. Three-dimensional gadolinium-enhanced MR angiography of the extracranial atherosclerotic carotid arteries: Two techniques
10. Evaluation of the aortoiliac and renal arteries: Comparison of breath hold, contrast-enhanced, three-dimensional MR angiography with conventional catheter angiography
11. Effect of gadolinium on phase-contrast MR angiography of the renal arteries
12. Renal arteries: Optimization of three-dimensional gadolinium-enhanced MR angiography with bolus-timing-independent fast multiphase acquisition in a single breath-hold
13. Fast MR angiography of the aortoiliac arteries and arteries of the lower extremity: Value of bolus-enhanced, whole-volume substraction technique?
14. Iliac artery stenosis measurements: Comparison of two-dimensional time-of-flight and three-dimensional dynamic gadolinium-enhanced MR angiography
15. Peripheral arterial disease: Gadolinium-enhanced MR angiography versus color-guided duplex US. A meta-analysis
16. Review: Contrast-enhanced coronary MRA
17. Coronary arteries: Breath hold, gadolinium-enhanced, three-dimensional MR angiography
18. Pilot MR evaluation of pharmacokinetics and relaxivity of specific blood pool agents for MR angiography
19. Physical, chemical, and biological evaluations of P760: A new gadolinium complex characterized by a low rate of interstitial diffusion
20. Pharmacokinetics of three gadolinium chelates with different molecular sizes shortly after intravenous injection in rabbits. Relevance to MR angiography
21. P760 and P 775: MRI contrast agents characterized by new pharmacokinetic properties
22. Coronary arteries: New design for three-dimensional arterial phantoms
23. Diagnosis of renal artery stenosis with magnetic resonance angiography and stenosis quantification
24. Projection-reconstruction methods: Fast imaging sequences and data processing
25. An analysis of fast imaging sequences with steady-state transverse magnetization refocusing
26. Optimizing three-dimensional gadolinium-enhanced magnetic resonance angiography. Original investigation
27. Scan optimization of gadolinium contrast-enhanced three-dimensional MRA of peripheral arteries with multiple bolus injections and in vitro validation of stenosis quantification
28. Evaluation of the effects of intravascular MR contrast media (Gadolinium Dendrimer) on 3D time of flight magnetic resonance angiography of the body
29. Carboxymethyl-dextran-gadolinium-DTPA as a blood pool contrast agent for magnetic resonance angiography
30. Vascular mapping using albumin-(Gd-DTPA), an intravascular MR contrast agent, and projection MR imaging
31. In vivo and in vitro evaluation of Gd-DTPA-polylysine as a macromolecular contrast agent for magnetic resonance imaging
32. Ultrasmall superparamagnetic iron oxyde particles (AMI 227) as a blood pool contrast agent for MR angiography: Experimental study in rabbits
33. Enhancement of phase-contrast MR angiography with superparamagnetic iron oxide
34. Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging
35. Safety, tolerance, biodistribution and MR imaging enhancement of the liver with Gd-BOPTA: Results of clinical pharmacologic and pilot imaging studies in non-patient and patient volunteers
36. 3D pulmonary perfusion and angiography with a new intravascular contrast agent BR22956/1 in detection of pulmonary flow and perfusion defects
37. MS-325: A small-molecule vascular imaging agent for magnetic resonance imaging
38. MS-325: Albumin-targeted contrast agent for MR angiography
39. Infarcted myocardium in pigs: MR imaging enhanced with slow-interstitial-diffusion gadolinium compound P 760
40. Magnetic resonance angiography with Gadomer-17. An animal study original investigation
41. Comparison of two blood pool contrast agent for 0.5 T MR angiography: Experimental study in rabbits
42. Vision: Human and electronic
43. Rose Model in MRI: Noise limitations on spatial resolution and implications for contrast enhanced MR angiography
44. Contrast enhanced magnetic resonance angiography of peripheral vessels. Different contrast agent applications and sequence strategies: A review
45. Breath-hold gadolinium-enhanced MR angiography of the major vessels at 1.0 T: Dose-response findings and angiographic correlation